RNA Supply Chain Solutions
-
Synthetic Research Grade sgRNA Manufacturing For CRISPR Experiments
11/28/2023
Consistently achieve high editing efficiency and quick turnaround time in as little as 7 days with synthetic sgRNA that pave your way to a successful CRISPR experiment.
-
Process Chemicals For RNA Drug Manufacturing
Make use of our portfolio of raw materials required for mRNA with an integrated offering for all process steps, from plasmid DNA (pDNA) to mRNA synthesis to final formulation.
-
Mitigate Contamination Risks With HTST Flash Pasteurization
5/2/2024
Gibco™ High-temperature, short-time (HTST) treatment of raw materials
HTST treatment currently available in North America
Simple sugar batch sizes ranging from 800 to 8,800 L
In-house HTST preparation can be expensive and cumbersome. Outsourcing this technology to Thermo Fisher Scientific can alleviate production bottlenecks and increase viral mitigation confidence.
Suitable and cost-effective for large volumes
Standard and custom bioprocessing containers available (5 L–1,000 L). Please contact your sales representative.
-
jetMESSENGER®: mRNA Transfection Reagent For Hard-To-Transfect Cells
3/21/2023
Learn about a highly efficient and gentle mRNA transfection reagent designed for outstanding transfection efficiency in hard-to-transfect cells, finally allowing relevant gene expression experiments in almost all cell types.
-
in vivo mRNA Delivery Using Liposome-Based Reagent
12/12/2022
in vivo-jetRNA®+ is a ready-to-use reagent that does not require formulation equipment that leads to 100% mRNA encapsulation leading to efficient mRNA delivery.
-
Advancing Innovative Plasmid DNA Manufacturing Solutions For CGT
3/13/2025
Having produced over 185,000 DNA lots, including 5,000+ cGMP batches, we are a trusted partner in plasmid DNA production from discovery to commercialization.
-
The Most Comprehensive Supply Chain Solutions For The Life Sciences Industry
1/5/2022
Cryoport has expanded beyond just temperature-controlled logistics — it’s now the premier provider of supply chain solutions for life sciences, supporting research, clinical trials, commercial cell therapies around the world.
-
Enabling mRNA Manufacturing For RNA-Based Vaccines And Therapeutics
2/9/2026
Learn about next-generation RNA polymerases that support diverse cap analog chemistries and modified nucleotides, ensuring high capping efficiency and sequence integrity for complex therapeutics.
-
mRNA Raw Materials: Supporting Your Journey To Market
12/5/2025
Implementing a quality-by-design approach for manufacturing inputs limits contamination risks and simplifies regulatory compliance. Validated processes ensure consistency when scaling operations.
-
High-Fidelity Nuclease For Therapeutic Breakthroughs
10/28/2024
The hfCas12Max nuclease offers superior gene editing with high fidelity, broad PAM recognition, minimal off-target effects, and compatibility across cell types for therapeutic applications.